AZ doing big things? LOLL!!

Quote

Anonymous

Guest
AstraZeneca ($AZN) scored big with the approval of Brilinta, which could potentially bring in $2 billion to $4 billion. AZ faced a potential obstacle when Americans in a study didn't respond as well to the therapy as people living outside the U.S. But the FDA signed off on the drug (AZ attributed the differing results to higher overall use of aspirin in the U.S.). The drugmaker also has slapped a premium price on the clotbuster: A wholesale cost of $7.24 per day, which is almost 20% more than its rival Plavix.


You guys will be lucky if you bring in $2.00 - $4.00 in annual revenue with a price margin THAT high! Good Luck...BAHAHHAAAA!!!!
 




Anonymous said:
AstraZeneca ($AZN) scored big with the approval of Brilinta, which could potentially bring in $2 billion to $4 billion. AZ faced a potential obstacle when Americans in a study didn't respond as well to the therapy as people living outside the U.S. But the FDA signed off on the drug (AZ attributed the differing results to higher overall use of aspirin in the U.S.). The drugmaker also has slapped a premium price on the clotbuster: A wholesale cost of $7.24 per day, which is almost 20% more than its rival Plavix.


You guys will be lucky if you bring in $2.00 - $4.00 in annual revenue with a price margin THAT high! Good Luck...BAHAHHAAAA!!!!
Click to expand...


And yet AZ raised the price in January.

LOL

Glad I never had that POS wantabe
 




Anonymous said:
And yet AZ raised the price in January.

LOL

Glad I never had that POS wantabe
Click to expand...

We don't know what they charge the insurance companies.

It's only for the poor blokes at retail and the government plans. The doctors will know who's got the bucks to fill the Rx for retail scripts. Trailer trash patients aren't getting their Rxed unless they are on government benefit, and the US government can't negotiate price by law, so why not raise the price to the moon? Everybody knows the US has unlimited money.
 












Top Bottom
Back
Quote